Duration of anticoagulation after first episode of unprovoked venous thromboembolism
Abdel-Razeq, H.N.; Radwi, G.R.
Saudi Medical Journal 25(11): 1776; Author Reply 1776-7
2004
ISSN/ISBN: 0379-5284 PMID: 15573235 Document Number: 569927
Document emailed within 1 workday
Related Documents
Prandoni, P.; Piovella, C.; Spiezia, L.; Dalla Valle, F.; Pesavento, R. 2011: Optimal duration of anticoagulation in patients with venous thromboembolism Indian Journal of Medical Research 134: 15-21Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Larsen, T.B. 2015: Unprovoked venous thromboembolism: Should we be looking for cancer? Ugeskrift for Laeger 177(48): V67480
Carcaterra, A.; Serratrice, J.; Righini, M.; Robert-Ebadi, H. 2018: Unprovoked venous thromboembolism : should we look for occult cancer ? Revue Medicale Suisse 14(623): 1840-1843
Poli, D.; Antonucci, E.; Ciuti, G.; Abbate, R.; Prisco, D. 2007: Anticoagulation quality and the risk of recurrence of venous thromboembolism Thrombosis and Haemostasis 98(5): 1148-1150
Farraj, R.S. 2004: Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Medical Journal 25(7): 848-851
Le Gal, G.ég.; Kovacs, M.J.; Carrier, M.; Do, K.; Kahn, S.R.; Wells, P.S.; Anderson, D.A.; Chagnon, I.; Solymoss, S.; Crowther, M.; Righini, M.; Lacut, K.; White, R.H.; Vickars, L.; Rodger, M. 2010: Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study Thrombosis and Haemostasis 104(3): 498-503
Hoyt, R. 2005: Readers' responses to the article entitled "anticoagulation therapy for venous thromboembolism" MedGenMed: Medscape general medicine 7(1): 49; author reply 48
Marchetti, M.; Pistorio, A.; Barosi, G. 2000: Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis Thrombosis and Haemostasis 84(5): 752-757
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Kevorkian, J-Philippe.; Virally, M-Laure.; Bergmann, J-François. 2007: D-dimer and duration of anticoagulation New England Journal of Medicine 356(4): 422; Author Reply 423
Fresán, A.; Apiquian, R.; Ulloa, R.E.; Loyzaga, C.; Nicolini, H.; Gómez, L. 2003: Premorbid functioning by gender and its relationship with duration of untreated psychosis in first psychotic episode Actas Espanolas de Psiquiatria 31(2): 53-58
Ajayi, A.A.; Horn, E.H.; Rubin, P.C. 1999: Evidence of in vivo platelet activation during heparin anticoagulation in pregnancy for prophlaxis or treatment of thromboembolism African Journal of Medicine and Medical Sciences 28(1-2): 113-115
Chunilal, S.D.; Brill-Edwards, P.A.; Stevens, P.B.; Joval, J.P.; McGinnis, J.A.; Rupwate, M.; Ginsberg, J.S. 2002: The sensitivity and specificity of a red blood cell agglutination D-dimer assay for venous thromboembolism when performed on venous blood Archives of Internal Medicine 162(2): 217-220